Jianwei Bi

2.0k total citations
31 papers, 1.5k citations indexed

About

Jianwei Bi is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Jianwei Bi has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Surgery and 9 papers in Oncology. Recurrent topics in Jianwei Bi's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Jianwei Bi is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Jianwei Bi collaborates with scholars based in China, United States and United Kingdom. Jianwei Bi's co-authors include Guoen Fang, Xuchao Xue, Kangkang Zhi, Yang Feng, Luming Zheng, Yan Gu, Ji-de Hua, Wei Guo, Liye Ma and Xuchao Xue and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Jianwei Bi

31 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianwei Bi China 16 937 906 267 243 206 31 1.5k
Cuijuan Zhang China 18 790 0.8× 527 0.6× 218 0.8× 89 0.4× 156 0.8× 39 1.1k
Xiaoan Tao China 17 485 0.5× 349 0.4× 209 0.8× 104 0.4× 182 0.9× 41 977
Kimishige Akino Japan 15 933 1.0× 219 0.2× 277 1.0× 157 0.6× 166 0.8× 24 1.3k
Xiaoqing Jiang China 14 425 0.5× 282 0.3× 378 1.4× 246 1.0× 407 2.0× 41 1.1k
Wen‐Liang Fang Taiwan 23 664 0.7× 655 0.7× 283 1.1× 359 1.5× 77 0.4× 61 1.5k
John I. Song United States 16 494 0.5× 256 0.3× 490 1.8× 166 0.7× 147 0.7× 34 1.1k
Jun Ye China 12 378 0.4× 243 0.3× 335 1.3× 140 0.6× 232 1.1× 18 850
Kira Bettermann Austria 9 545 0.6× 424 0.5× 125 0.5× 116 0.5× 81 0.4× 11 983

Countries citing papers authored by Jianwei Bi

Since Specialization
Citations

This map shows the geographic impact of Jianwei Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianwei Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianwei Bi more than expected).

Fields of papers citing papers by Jianwei Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianwei Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianwei Bi. The network helps show where Jianwei Bi may publish in the future.

Co-authorship network of co-authors of Jianwei Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Jianwei Bi. A scholar is included among the top collaborators of Jianwei Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianwei Bi. Jianwei Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Weiping, Kailian Zheng, Bin Song, et al.. (2019). OCIAD1 promoted pancreatic ductal adenocarcinoma migration by regulating ATM. Pancreatology. 19(5). 751–759. 3 indexed citations
2.
Luo, Tianhang, Jiangman Zhao, Zhengmao Lu, et al.. (2018). Characterization of long non-coding RNAs and MEF2C-AS1 identified as a novel biomarker in diffuse gastric cancer. Translational Oncology. 11(5). 1080–1089. 27 indexed citations
3.
Ji, Weiping, Tao You, Zhuo Shao, et al.. (2018). Enhanced recovery after surgery decreases intestinal recovery time and pain intensity in patients undergoing curative gastrectomy. Cancer Management and Research. Volume 10. 3513–3520. 6 indexed citations
4.
Chu, Bingfeng, et al.. (2016). Downregulation of Notch-regulated Ankyrin Repeat Protein Exerts Antitumor Activities against Growth of Thyroid Cancer. Chinese Medical Journal. 129(13). 1544–1552. 5 indexed citations
5.
Lu, Zhengmao, Tianhang Luo, Mingming Nie, et al.. (2015). TSPAN1 functions as an oncogene in gastric cancer and is downregulated by miR‐573. FEBS Letters. 589(15). 1988–1994. 37 indexed citations
6.
Zhang, Hao, Gusheng Tang, Xudong Wang, et al.. (2015). Caveolin-1 is a Modulator of Fibroblast Activation and a Potential Biomarker for Gastric Cancer. International Journal of Biological Sciences. 11(4). 370–379. 36 indexed citations
7.
Zhang, Xin, et al.. (2014). Long-term complications requiring reoperations after laparoscopic adjustable gastric banding: a systematic review. Surgery for Obesity and Related Diseases. 11(4). 956–964. 39 indexed citations
8.
Guo, Wei, et al.. (2014). Experimental Study on Sustained-release 5-Fluorouracil Implantation in Canine Peritoneum and Para-aortic Abdominalis. Asian Pacific Journal of Cancer Prevention. 15(1). 407–411. 3 indexed citations
10.
Lu, Zhengmao, Tianhang Luo, Mingming Nie, et al.. (2013). Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy. Tumor Biology. 35(4). 2941–2948. 23 indexed citations
11.
Huang, Shengdong, Yang Yuan, Hao Tang, et al.. (2013). Tumor Cells Positive and Negative for the Common Cancer Stem Cell Markers Are Capable of Initiating Tumor Growth and Generating Both Progenies. PLoS ONE. 8(1). e54579–e54579. 26 indexed citations
12.
Lu, Zhengmao, Tianhang Luo, Mingming Nie, et al.. (2013). Genetic polymorphisms ofXRCC1gene and susceptibility to gastric cancer in Chinese Han population. Biomarkers. 18(6). 542–546. 3 indexed citations
13.
Feng, Yang, Jianwei Bi, Xuchao Xue, et al.. (2012). Up‐regulated long non‐coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS Journal. 279(17). 3159–3165. 390 indexed citations
14.
Feng, Yang, Xuchao Xue, Jianwei Bi, et al.. (2012). Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. Journal of Cancer Research and Clinical Oncology. 139(3). 437–445. 236 indexed citations
15.
Wu, Jian, Zhengmao Lu, Mingming Nie, et al.. (2011). Optimization of cryopreservation procedures for porcine endothelial progenitor cells. Journal of Bioscience and Bioengineering. 113(1). 117–123. 6 indexed citations
16.
Chen, Zhangjing, Jufang Wu, Yingyuan Zhang, et al.. (2010). Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. BMC Infectious Diseases. 10(1). 217–217. 36 indexed citations
17.
Zhi, Kangkang, et al.. (2010). Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers. Journal of Experimental & Clinical Cancer Research. 29(1). 66–66. 63 indexed citations
18.
Fang, Guoen, et al.. (2008). Clinical management of abdominal trauma. Chinese Journal of Traumatology. 11(4). 239–242. 1 indexed citations
19.
Zhang, Bin, Guanghua Rong, Huafeng Wei, et al.. (2008). The prevalence of Th17 cells in patients with gastric cancer. Biochemical and Biophysical Research Communications. 374(3). 533–537. 215 indexed citations
20.
Lu, Zhengmao, et al.. (2008). A small interfering RNA targeting osteopontin as gastric cancer therapeutics. Cancer Letters. 272(1). 148–159. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026